Eledon Pharmaceuticals, Inc. (ELDN)Healthcare | Biotechnology | Irvine, United States | NasdaqCM
3.20 USD
-0.12
(-3.614%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.21 +0.01 (0.312%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 6:08 a.m. EDT
The long-term outlook is severely compromised by a decade-long structural decline; the stock has lost nearly 99% of its value over the last nine years, with seven of those years showing negative returns. Despite a recent surge in price and positive news regarding diabetes trials, the underlying business shows no signs of recovery, evidenced by negative earnings, negative free cash flow, and a return on equity of -110%. The balance sheet, while currently debt-light, is being eroded by significant cash burn. Short-term momentum is mixed; the stock recently rallied but is now trading below its 50-day moving average, and the statistical forecast model offers no directional guidance. Options activity confirms a bearish sentiment, with traders aggressively buying puts to hedge against further deterioration rather than betting on a near-term reversal. Without a proven path to profitability or a clear turnaround in revenue growth, the investment case remains fundamentally broken. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.055295 |
| AutoARIMA | 0.056801 |
| AutoETS | 0.056802 |
| AutoTheta | 0.143153 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 1.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.302 |
| Excess Kurtosis | -1.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.648 |
| Market Cap | 260,035,696 |
| Forward P/E | -4.16 |
| Beta | 0.96 |
| Website | https://eledon.com |
As of Aug. 22, 2026, 6:08 a.m. EDT: Speculators are heavily positioned for downside protection, with massive open interest in out-of-the-money puts relative to calls. The put/call ratio is skewed significantly toward selling, while call volume is concentrated at strikes far above the current price, indicating a lack of immediate bullish conviction despite some speculative upside bets.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.254902 |
| Address1 | 19,800 MacArthur Boulevard |
| Address2 | Suite 250 |
| All Time High | 4,860.0 |
| All Time Low | 1.07 |
| Ask | 4.13 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 882,010 |
| Average Daily Volume3 Month | 1,268,996 |
| Average Volume | 1,268,996 |
| Average Volume10Days | 882,010 |
| Beta | 0.956 |
| Bid | 2.38 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 0.89 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.2 |
| Current Ratio | 7.896 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.32 |
| Day Low | 3.17 |
| Debt To Equity | 0.648 |
| Display Name | Eledon Pharmaceuticals |
| Dividend Date | 1,601,856,000 |
| Earnings Timestamp End | 1,794,600,000 |
| Earnings Timestamp Start | 1,794,600,000 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 171,746,688 |
| Eps Current Year | -0.9325 |
| Eps Forward | -0.77 |
| Eps Trailing Twelve Months | -0.87 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.7002 |
| Fifty Day Average Change | -0.50020003 |
| Fifty Day Average Change Percent | -0.13518189 |
| Fifty Two Week Change Percent | 25.4902 |
| Fifty Two Week High | 4.6 |
| Fifty Two Week High Change | -1.3999999 |
| Fifty Two Week High Change Percent | -0.3043478 |
| Fifty Two Week Low | 1.35 |
| Fifty Two Week Low Change | 1.85 |
| Fifty Two Week Low Change Percent | 1.3703704 |
| Fifty Two Week Range | 1.35 - 4.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,410,960,600,000 |
| Float Shares | 74,596,112 |
| Forward Eps | -0.77 |
| Forward P E | -4.155844 |
| Free Cashflow | -45,104,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 33 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -3.61445 |
| Fullday Price | 3.21 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00329 |
| Held Percent Institutions | 0.62481 |
| Implied Shares Outstanding | 81,261,152 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,601,856,000 |
| Last Split Factor | 1:18 |
| Long Business Summary | Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc.; and a strategic collaboration with NewcelX Ltd. for the development of the NCEL-101 therapy for Type 1 Diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. |
| Long Name | Eledon Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 260,035,696 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_62494905 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -98,561,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 269,787,024 |
| Number Of Analyst Opinions | 5 |
| Open | 3.29 |
| Operating Cashflow | -73,857,000 |
| Operating Margins | 0.0 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 949 238 8090 |
| Post Market Change | 0.00999999 |
| Post Market Change Percent | 0.3124997 |
| Post Market Price | 3.21 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 3.32 |
| Price Eps Current Year | -3.4316354 |
| Price Hint | 4 |
| Price To Book | 3.5955057 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.565 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -3.61445 |
| Regular Market Day High | 3.32 |
| Regular Market Day Low | 3.17 |
| Regular Market Day Range | 3.17 - 3.32 |
| Regular Market Open | 3.29 |
| Regular Market Previous Close | 3.32 |
| Regular Market Price | 3.2 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 1,014,524 |
| Return On Assets | -0.39023998 |
| Return On Equity | -1.10706 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 81,261,152 |
| Shares Percent Shares Out | 0.0774 |
| Shares Short | 6,289,078 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 5,522,678 |
| Short Name | Eledon Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.0774 |
| Short Ratio | 6.52 |
| Source Interval | 15 |
| State | CA |
| Symbol | ELDN |
| Target High Price | 12.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 8.0 |
| Total Cash | 88,756,000 |
| Total Cash Per Share | 1.092 |
| Total Debt | 467,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.87 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.898425 |
| Two Hundred Day Average Change | 0.30157495 |
| Two Hundred Day Average Change Percent | 0.104047865 |
| Type Disp | Equity |
| Volume | 1,014,524 |
| Website | https://eledon.com |
| Zip | 92,612 |